Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: A consensus modelling approach

BACKGROUND: Respiratory syncytial virus (RSV) is the major viral cause of infant and childhood lower respiratory tract disease worldwide. Defining the optimal target product profile (TPP) is complicated due to a wide range of possible vaccine properties, modalities and an incomplete understanding of...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Vaccine
Auteurs principaux: Pan-Ngum, Wirichada, Kinyanjui, Timothy, Kiti, Moses, Taylor, Sylvia, Toussaint, Jean-François, Saralamba, Sompob, Van Effelterre, Thierry, Nokes, D. James, White, Lisa J.
Format: Artigo
Langue:Inglês
Publié: Elsevier Science 2017
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5221409/
https://ncbi.nlm.nih.gov/pubmed/27914740
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2016.10.073
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires